Bloomsbury Publishing News

Bristol Myers Squibb announced a quarterly dividend on Wednesday, June 19th, ARN reports.

Bristol-Myers Squibb Company today announced that its Board of Directors has elected Dinesh C. Paliwal to the Board, effective July 1, 2013.

AstraZeneca and Bristol-Myers Squibb Announce Top Line Results for SAVOR-TIMI-53 Cardiovascular Outcomes Trial of Onglyza A )-- Bristol-Myers Squibb Company and AstraZeneca today announced top line results of the Phase 4 SAVOR-TIMI-53 clinical trial of Onglyza A .

Simcere Pharmaceutical Group recently announced that it has entered into a strategic agreement with Bristol-Myers Squibb Company .

Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of Investigational Agent Elotuzumab in Combination with Lenalidimide and Dexamethasone in Previously-Treated Multiple Myeloma a Median progression-free survival of 33 months reached after longer-term follow up in patients treated with elotuzumab 10 ... (more)

As the world of big drug companies streamlines operations by shrinking research-and-development staffs and outsourcing tasks amid patent losses on key medicines, the benefit is two-fold for specialty firms contracted to take on the work.

Mindray Medical of Shenzhen will pay $105 million to acquire Zonare Medical Systems, a California high-end ultrasound machine maker .

Bristol-Myers Squibb Company and AbbVie today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses of the investigational monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone.

Founded in 2002, TBWA\WorldHealth is a healthcare marketing services network that combines medical expertise with a consumer-marketing heritage and a unique approach to solving client problems and driving growth through the proprietary strategies of Disruption and Media Arts.

Bristol-Myers Squibb and Simcere Pharmaceutical Group have expanded their strategic partnership to collaborate on the development and commercialization of the subcutaneous formulation of BMS's rheumatoid arthritis drug Orencia in China.

The firm currently has a buy rating on the stock. A number of other firms have also recently commented on BMY.

Bloomsbury Publishing, Inc., a general interest publisher of adult and children's books and U.S-based subsidiary of Bloomsbury Publishing Plc, has selected UCaaS solution for its new office space in Manhattan.

When it comes to assessing the outlook for drugmakers, investors really only care about the pipeline of new drugs.

Bristol-Myers Squibb : Jim Cramer ranked this stock a Buy . Cramer previously ranked this stock a Buy on May 20, 2013.

UBS AG's price target indicates a potential upside of 1.50% from the stock's previous close.

As investors were picking up the pieces after the dot-com implosion, they came across another troubled sector.

Position Profile Working closely with sales operations manager to ensure accurate and timely flow of title metadata to distributor systems; support of sales operations and sales departments.

Federal prosecutors say a former Bristol-Myers Squibb executive has admitted using his high-level position and access to nonpublic information to make about $310,000 from illegal insider trades.

Organovo Holdings, Inc. , a biotechnology company focused on delivering breakthrough three-dimensional bioprinting technology, today announced that Tamar D. Howson has been appointed to the Company's Board of Directors.

It is not unusual for stocks on a tear to overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb.